Lotus Eye Hospital Institute Ltd vs Molbio Diagnostics Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Lotus Eye Hospital & Institute Ltd is ₹ 112.75 as of 23 Oct 15:30 . The P/E Ratio of Lotus Eye Hospital & Institute Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe P/E Ratio of Molbio Diagnostics Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 years The Market Cap of Lotus Eye Hospital & Institute Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Market Cap of Molbio Diagnostics Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 6 years The Revenue of Lotus Eye Hospital & Institute Ltd is ₹ 0 crore as of Jun '25 .The Revenue of Molbio Diagnostics Ltd is ₹ 100.47 crore as of Jun '25 . The EBITDA of Lotus Eye Hospital & Institute Ltd is ₹ 0 crore as of Jun '25 .The EBITDA of Molbio Diagnostics Ltd is ₹ -15.35 crore as of Jun '25 . The Net Profit of Lotus Eye Hospital & Institute Ltd is ₹ 0 crore as of Jun '25 .The Net Profit of Molbio Diagnostics Ltd is ₹ -23.94 crore as of Jun '25 . The Dividend Payout of Lotus Eye Hospital & Institute Ltd changed from 66.24 % on March 2021 to 0 % on March 2026 . This represents a CAGR of -100.00% over 6 yearsThe Dividend Payout of Molbio Diagnostics Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Lotus Eye Hospital & Institute Ltd

Lotus Eye Hospital & Institute Limited, a trust hospital, was originally incorporated as 'Kalaivani Health Centre Pvt.
Limited' on 14 March, 1997.
The name of the Company was changed to 'Lotus Eye Care Hospital Pvt.
Limited' on 23 January, 2006 and later on, the Company was converted into a Public Limited Company on October 16, 2007 and subsequently, the name was changed to Lotus Eye Hospital & Institute Limited on April 12, 2013. Founded in 1990 by renowned ophthalmic surgeon late Dr. S.K. Sundaramoorthy, the Company operates 9 Eye Care centers in Tamil Nadu and Kerala: 7 Centres in Tamil Nadu: Coimbatore (Peelamedu, RS puramand Saravanampatti), Salem , Tirupur Mettupalayam and Karur. 2 Centresin Kerala: Kochi and Mulanthuruthy. Lotus Eye Care Hospital is the state of art eye care hospital group functioning in South India with specialization in super-specialty service related to eye care.

About Molbio Diagnostics Ltd

Molbio Diagnostics Limited was originally incorporated as Molbio Diagnostics Private Limited' at Panaji, as a private company dated October 20, 2000.
Thereafter, Company was converted from a private limited company to a public limited company, and the name of Company was changed to Molbio Diagnostics Limited, and a fresh certificate of incorporation dated January 16, 2025 was issued to Company by the RoC. Company is innovative point-of-care (POC) diagnostics company focused on expanding access to accurate, rapid and cost-effective healthcare technologies to diagnose infectious and non-communicable diseases.
The Company entered into a joint venture agreement in August, 2011 with Bigtec Innovations Private Limited and Bigtec Private Limited, which started operations in 2000.
Bigtec Innovations Private Limited got merged with the Company in 2015.

FAQs for the comparison of Lotus Eye Hospital & Institute Ltd and null

Which company has a larger market capitalization, Lotus Eye Hospital & Institute Ltd or Molbio Diagnostics Ltd?

Market cap of Lotus Eye Hospital & Institute Ltd is 234 Cr while Market cap of Molbio Diagnostics Ltd is 14,262 Cr

What are the key factors driving the stock performance of Lotus Eye Hospital & Institute Ltd and Molbio Diagnostics Ltd?

The stock performance of Lotus Eye Hospital & Institute Ltd and Molbio Diagnostics Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Lotus Eye Hospital & Institute Ltd and Molbio Diagnostics Ltd?

As of October 25, 2026, the Lotus Eye Hospital & Institute Ltd stock price is INR ₹112.75. On the other hand, Molbio Diagnostics Ltd stock price is INR ₹1237.65.

How do dividend payouts of Lotus Eye Hospital & Institute Ltd and Molbio Diagnostics Ltd compare?

To compare the dividend payouts of Lotus Eye Hospital & Institute Ltd and Molbio Diagnostics Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.